CLINICAL TRIALS PROFILE FOR ADENOCARD
✉ Email this page to a colleague
All Clinical Trials for ADENOCARD
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01690884 ↗ | Effect of Ticagrelor vs. Dipyridamole on Adenosine Uptake | Completed | Vanderbilt University | Phase 1 | 2012-08-01 | The investigators are trying to determine if a single dose of Ticagrelor will increase delivery of intraarterially-infused adenosine into the forearm interstitium, consistent with adenosine reuptake blockade. |
| NCT02608944 ↗ | Comparison of Quantitative MRI Perfusion Methods With Quantitative PET Perfusion Imaging | Withdrawn | University of Utah | N/A | 2012-09-30 | This work seeks to develop, evaluate and use new MRI methods for non-invasive quantitative assessment of myocardial perfusion and perfusion reserve (MPR), and to compare with quantitative PET imaging. |
| NCT03738943 ↗ | Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults | Completed | Colorado State University | Early Phase 1 | 2019-02-07 | Previous research has identified adenosine triphosphate (ATP) as an important vasodilator that is released from red blood cells during exercise and exposure to hypoxic environments in adult humans. Further, older adults appear to have lower blood flow during both of these stressors and also have lower amounts of ATP released from their red blood cells. However, the contribution of ATP to vasodilation in response to exercise and hypoxia is currently unknown due to the lack of an effective ATP receptor antagonist. We aim to determine whether Vitamin B6 or its metabolite, Pyridoxal-5-Phosphate (PLP) is an effective ATP receptor antagonist. |
| NCT04600115 ↗ | New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF) | Recruiting | National Heart, Lung, and Blood Institute (NHLBI) | Early Phase 1 | 2017-03-03 | This study's main specific aims are; 1. To develop robust acquisition and reconstruction methods specifically for the study of microvascular cardiac remodeling with MRI which will include very innovative quantitative perfusion methods, as well as fibrosis quantification, longitudinal strain, and phase contrast imaging for flow. 2. Test the new methods for identifying the clinical task of characterizing HFpEF. |
| NCT04600115 ↗ | New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF) | Recruiting | University of Utah | Early Phase 1 | 2017-03-03 | This study's main specific aims are; 1. To develop robust acquisition and reconstruction methods specifically for the study of microvascular cardiac remodeling with MRI which will include very innovative quantitative perfusion methods, as well as fibrosis quantification, longitudinal strain, and phase contrast imaging for flow. 2. Test the new methods for identifying the clinical task of characterizing HFpEF. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ADENOCARD
Condition Name
Clinical Trial Locations for ADENOCARD
Trials by Country
Clinical Trial Progress for ADENOCARD
Clinical Trial Phase
Clinical Trial Sponsors for ADENOCARD
Sponsor Name
